Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingre Heji in Acute Upper Respiratory Tract Infection
NCT06520618Phase 2Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- HMF (Herbal Medicine Formulation)
- Countries
- 1
01
Overview
A Phase 2 trial of Qing Re He Ji in acute upper respiratory tract infection (URI), sponsored by Shengjing Hospital of China Medical University. Started Feb 2023; status: completed.
02
Drugs
Qing Re He Ji
03
Conditions
acute upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT06520618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06520618.